Association of Cardiovascular Risk Factors with Pattern of Lower Limb Atherosclerosis in 2659 Patients Undergoing Angioplasty  by Diehm, N. et al.
*Correspond
ogy, Swiss C
strasse, 3010
E-mail address
1078–5884/00Association of Cardiovascular Risk Factors with Pattern
of Lower Limb Atherosclerosis in 2659 Patients
Undergoing Angioplasty
N. Diehm,1 A. Shang,2 A. Silvestro,1 D.-D. Do,1 F. Dick,3 J. Schmidli,3
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SwitzerlandObjectives. Aim of this study is to correlate distribution pattern of lower limb atherosclerosis with cardiovascular risk
factor profile of patients with peripheral arterial occlusive disease (PAD).
Patients and methods. Analysis is based on a consecutive series of 2659 patients (1583 men, 1076 women, 70G11 years)
with chronic PAD of atherosclerotic origin undergoing primary endovascular treatment of lower extremity arteries. Pattern
of atherosclerosis was grouped into iliac (nZ1166), femoropopliteal (nZ2151) and infrageniculate (nZ888) disease defined
according to target lesions treated. A multivariable multinomial logistic regression analysis was performed to assess relation
with age, gender and classical cardiovascular risk factors (diabetes mellitus, arterial hypertension, hypercholesterolemia,
cigarette smoking) using femoropopliteal disease as reference.
Results. Iliac disease was associated with younger age (RRR 0.95 per year of age, 95%-CI 0.94–0.96, p!0.001), male
gender (RRR 1.32, 95%-CI 1.09–1.59, pZ0.004) and cigarette smoking (RRR 2.02, 95%-CI 1.68–2.42, p!0.001).
Infrageniculate disease was associated with higher age (RRR 1.02, 95%-CI 1.01–1.02, p!0.001), male gender (RRR 1.23,
95%-CI 1.06–1.41, pZ0.005) and diabetes mellitus (RRR 1.68, 95%-CI 1.47–1.92, p!0.001). Hypercholesterolemia was
less prevalent in patients with lesions below the knee (RRR 0.82, 95%-CI 0.71–0.94, pZ0.006), whereas no distinct pattern
was apparent related to arterial hypertension.
Conclusion. Clinical phenotype of peripheral atherosclerosis varies with prevalence of cardiovascular risk factors
suggesting differences in mechanisms involved in iliac as compared with infrageniculate lesions. Identification of molecular
mechanism might have influence on future therapeutic strategies in PAD patients.Keywords: Age; Cohort study; Diabetes mellitus; Gender; Hypercholesterolemia; Hypertension; Smoking.Introduction
Atherosclerosis is the leading cause of death in
western countries and represents one of the major
problems in vascular medicine.1–3 The systemic nature
of atherosclerotic disease is clearly evident from the
frequent concurrence of coronary, cerebrovascular and
peripheral arterial disease (PAD),4–6 with plaque
rupture leading to atherothrombosis.
Large epidemiological and autopsy-based studies
have shown that distribution, extent and progression
of atherosclerosis are influenced by cardiovascularing author. Iris Baumgartner, MD, Division of Angiol-
ardiovascular Center, University Hospital, Freiburg-
Bern, Switzerland.
: iris.baumgartner@insel.ch
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Cigarette smoking and hypercholesterolemia are
most important in coronary artery disease,9,13 arterial
hypertension and diabetes mellitus are more fre-
quent among patients with cerebrovascular
disease.10,14 Lower extremity atherosclerosis is con-
sidered to be strongly related to smoking and
diabetes mellitus.4,7,9,15 However, there are striking
dissimilarities between arterial regions of the lower
extremities16–21 with the predominant below knee
involvement in diabetic patients most obvious.17
The aim of this cohort study of patients under-
going primary endovascular treatment of lower limb
arteries is to analyse risk factor association with
distribution pattern of peripheral atherosclerotic
target lesions.Eur J Vasc Endovasc Surg 31, 59–63 (2006)
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The cohort originates from a consecutive registry of
patients with endovascular therapy in a tertiary
referral center responsible for peripheral vascular
service in a population of about one million subjects.
Between January 1996 and June 2003, 2659 patients
(1076 women, mean age 70G11 years) with primary
angioplasty (Gstenting) of lower extremity arteries
were enrolled (3346 limbs, 4205 target lesions).
All patients had chronic PAD of Fontaine stages II–
IV of atherosclerotic origin. Patients with acute limb
ischemia, non-atherosclerotic lesions and redo inter-
ventions were excluded from analysis.
Prior to endovascular revascularization, all patients
had undergone clinical workup and arterial duplex
ultrasound to confirm findings suspected by clinical
examination.
Target lesions treated defined relevant atherosclero-
tic disease manifestation. Location of target lesions
was grouped as iliac or proximal (common, external
and internal iliac artery), femoropopliteal (common,
superficial and deep femoral arteries, popliteal artery)
and infrageniculate or distal (tibiofibular trunk,
anterior and posterior tibial arteries, fibular artery)
disease. Risk factors included in the statistical model
were age, gender, diabetes mellitus, arterial hyperten-
sion, hypercholesterolemia and cigarette smoking. The
presence of diabetes mellitus was defined by fasting
blood sugar O120 mg/dL or glycosylated haemo-
globin O6% or if the patient was on hypoglycemic
drugs. The presence of arterial hypertension was
defined by systolic blood pressure O140 mmHg
and/or diastolic blood pressure O80 mmHg, or if
the patient consumed any antihypertensive drug. The
presence of hyperlipidemia was defined by total
cholesterol level O5 mmol/L, or high-density lipo-
protein (HDL) cholesterol !1 mmol/L, or triglycer-
ides O2 mmol/L, or if the patient consumed any lipid-
lowering drug. Furthermore, patients were classified
as smokers and non-smokers. A smoking history
(current or former smokers) was established in
patients who had 1 pack-year or more of tobacco use
based on patient interview or chart documentation.Table 1. Demographic data of 2659 patients included in the cohort
Patient characteristics
Male, n 1583 (59.5%)
Age (meanGSD), years 70G11
Diabetes mellitus, n 891 (33.5%)
Hypertension, n 1497 (56.3%)
Hypercholesterinemia, n 1215 (45.7%)
Current smoking, n 1144 (43.0%)Statistics
The Department of Social and Preventive Medicine,
University of Bern performed statistical analysis.
Descriptive analyses of socio-demographic character-
istics were based on patient characteristics at the time
of the first intervention. Demographic and clinical
characteristics of study population are reported asEur J Vasc Endovasc Surg Vol 31, 1 2006meanGSD for continuous variables and as number
(percentage) for categorical variables. Each target
lesion was counted once and classified according to
its location (iliac, femoropopliteal, infragenigular). We
used multivariable multinomial logistic regression to
analyse risk factor associations at the level of lesions.
Femoropopliteal lesions were defined as reference
category. Since, some patients had more than one
target lesion, robust standard errors were used to
allow for the multilevel nature of the data. Results are
shown as relative risk ratio (RRR) with 95% confidence
intervals (95%-CI). A p!0.05 was considered statisti-
cally significant. All analyses were performed in Stata
version 8.2 (Stata Corporation, College Station, Texas).Results
Demographic data among the 2659 patients treated are
shown in Table 1. Location of the 4205 atherosclerotic
target lesions in 3346 limbs treated was in the iliac
territory in 27.7% (1166 lesions/883 patients), femor-
opopliteal 51.2% (2151 lesions/1802 patients) and
infragenicular 21.1% (888 lesions/801 patients),
respectively.
Results from multivariable multinomial logistic
regression analysis showing the association between
atherosclerotic target lesions (iliac, femoropoliteal,
infragenicular) with risk factors are given in Table 2
and Fig. 1. Statistically, femoropopliteal involvement
was set with a RRR of 1. Risk for atherosclerotic
disease increased with age, giving a RRR of 0.95 (95%-
CI 0.94–0.96, p!0.001) for iliac, and a RRR of 1.02
(95%-CI 1.01–1.02, p!0.001) for infragenicular lesions
calculated per year of age. A more pronounced
centrifugal pattern was seen in patients with diabetes
mellitus (RRR 0.59, 95%-CI 0.49–0.72, p!0.001 for iliac,
and RRR 1.68, 95%-CI 1.47–1.92, p!0.001 for infra-
genicular lesions, respectively), whereas cigarette
smoking demonstrated the inverse association (RRR
2.02, 95%-CI 1.68–2.42, p!0.001 for iliac, and RRR 0.50,
95%-CI 0.42–0.59, p!0.001 for infragenicular lesions,
respectively). Hypercholesterolemia showed a similar
pattern as seen related to smoking, but missed
statistical significance for iliac disease involvement.
Table 2. Multivariable multinominal logistic regression analysis to calculate risk factor associations at the level of atherosclerotic target
lesions (nZ4205)
Risk factor Atherosclerotic lesions
Iliac Femoropopliteal
(reference)
Infragenicular
RRR 95%-CI RRR RRR 95%-CI
Age (per year) 0.95 0.94–0.96 1 1.02 1.01–1.02
Male gender 1.32 1.09–1.59 1 1.23 1.06–1.41
Diabetes mellitus 0.59 0.49–0.72 1 1.68 1.47–1.92
Hypertension 1.17 0.99–1.39 1 1.06 0.92–1.22
Hypercholesterole-
mia
1.15 0.98–1.36 1 0.82 0.71–0.94
Current smoking 2.02 1.68–2.42 1 0.50 0.42–0.59
Femoropopliteal lesions were used as reference with a relative risk ratio (RRR) of 1.
Atherosclerosis in Peripheral Arteries 61Gender was associated with femoropopliteal lesions in
females, in contrast to iliac (RRR 1.32, 95%-CI 1.09–1.59
pZ0.004) and infragenicular (RRR 1.23, 95%-CI 1.06–
1.41, pZ0.005) manifestation of target lesions in males.
Arterial hypertension had no significant discriminat-
ing effect for a distinct pattern of atherosclerosis
(Table 2).Discussion
This cohort study of patients with chronic PAD
undergoing primary endovascular treatment high-
lights a statistically significant association between
cardiovascular risk factors present and pattern of
atherosclerotic lesions of the lower limbs. Current
smoking is closely related to proximal disease,
whereas higher age and diabetes mellitus predispose
to distal atherosclerotic disease involvement. More-
over, a striking difference with more femoropoplitealFig. 1. Association of risk factors with the level of atheroscl
illustrates the association of risk factor with pattern of atherostarget lesions in females compared with significantly
more iliac and infragenicular target lesions in males is
evident.
Hypotheses explaining site-selectivity of athero-
sclerotic lesions include hemodynamic stress related
to arterial geometry and anatomic, cellular or bio-
chemical variations in the arterial wall.22 Iliac arteries
are characterized by elastic properties, whereas
femoral and infragenicular arteries contain progress-
ively more muscular elements. Moreover, the relation
of arterial lumen to wall thickness decreases from
proximal to distal, both generating an alteration in
arterial flow and shear stress associated with endo-
thelial dysfunction and early type I–III atherosclerotic
lesions at sites with low shear rate and disturbed flow.
Age-related effects on site-selectivity of athero-
sclerotic lesions within the peripheral circulation
were observed in several small sized angiographic
studies.19–21,23,24 In the presented study, patients with
iliac obstructions are shown to be substantiallyerotic target lesions. Red overlay on the anatomic cartoon
clerotic lesions.
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to the development of lesions in femoropopliteal and
infrageniculate arteries, suggesting that mechanisms
of premature atherosclerosis in peripheral arteries are
different from the senescent form.
Significantly, more men were treated in this study
reflecting observations from other studies that evol-
ution of PAD is strongly influenced by gender, with
male dominance.13,25–29 Moreover, atherosclerosis
pattern significantly differed between male and female
patients, as is known from clinical practice. In contrary
to the strong association of iliac disease with male
gender, a pattern of isolated manifestation of athero-
sclerosis in the aorto-iliac segment (Brewster type I
disease) has been described in younger females.23,24,30
Differences from the present observation are explained
by the fact that for statistical reasons aortic target
lesions were not considered. A similar striking female
dominance for isolated aorto-iliac lesions was seen in
patients from the registry if these lesions were
included (data not shown).
Diabetes mellitus is the most obvious risk factor for
atherosclerotic involvement of infragenicular arteries.
This fact has first been mentioned by Strandness in
1964, and has been confirmed by several authors
including this series.19,21,31–36
The following limitations of the present cohort
study have to be addressed. Atherosclerotic pattern
was defined by endovascular target lesions treated.
Consequently, the entire atherosclerotic burden was
not considered for analysis. However, PTA target
lesions represent clinically relevant atherosclerosis,
although it does not contain information about early
atherosclerotic lesions.
We are aware that grouping the treated vessels into
three categories might be an over-simplification.
We do not think that a more differentiated analysis
of vascular territories would have changed our basic
message. Furthermore, we cannot rule out a bias
created by only including patients selected for
endovascular therapy.
In conclusion, our results show significant variation
in site-selectivity of atherosclerotic lesions related to
cardiovascular risk factor profile present. The findings
suggest profound differences in molecular mechan-
isms involved. The use of gene profiling and novel
imaging approaches will help to unravel complex
interactions.References
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